Phase I, dose-escalation, clinical trial of MVA-Brachyury-TRICOM vaccine demonstrating safety and brachyury-specific T cell responses

類似資料

• Phase I Study of a Poxviral TRICOM-Based Vaccine Directed Against the Transcription Factor Brachyury
  著者:: Heery, Christopher R., 等
  出版事項: (2017)
• Identification of tumor associated immune responses against brachyury, a transcription factor and driver of EMT, in chordoma patients receiving a yeast-brachyury vaccine (gi-6301)
  著者:: Donahue, Renee N, 等
  出版事項: (2014)
• Effect of age and cancer on peripheral immune cell subsets and their PD-1 and PD-L1 expression
  著者:: Grenga, Italia, 等
  出版事項: (2015)
• Digital immunohistochemistry analysis of intratumoral immune infiltrates in prostate cancer patients treated with intraprostatic/systemic PSA-TRICOM vaccine
  著者:: Farsaci, Benedetto, 等
  出版事項: (2013)
• Analyses of 123 Peripheral Human Immune Cell Subsets: Defining Differences with Age and between Healthy Donors and Cancer Patients Not Detected in Analysis of Standard Immune Cell Types
  著者:: Lepone, Lauren M., 等
  出版事項: (2016)